₹17.87
₹-0.94 (-5.00%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹281 Cr
P/E
21.80
ROE
13.73%
ROCE
15.37%
About Take Ltd
Take Solutions In the fast-growing Life Sciences space, TAKE offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise. Our range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums. With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers successful outcomes for clients. Our global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers.
Founded
2000
CEO
N/A
Employees
9
HQ
Chennai, Tamil Nadu
About Take Ltd
Take Solutions In the fast-growing Life Sciences space, TAKE offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise. Our range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums. With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers successful outcomes for clients. Our global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers.
Founded:2000
CEO:N/A
Employees:9
HQ:Chennai, Tamil Nadu
Finished Products
1Income from sale of services
₹6.32CrRaw Materials
No raw materials reported
This company hasn’t disclosed any raw materials breakdown.
Price Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹50
52W Low
₹10
Volume82.92K
Avg VolumeN/A
Beta0.47
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
21.80x
Valuation
P/B Ratio
9.05x
Valuation
EPS
₹0.87
Valuation
Dividend Yield
0.00%
Valuation
ROE
13.73%
Profitability
ROCE
15.37%
Profitability
Revenue by Segment
Contribution & growth by business line
Life Sciences
-64.4%95.8%
₹741.17 Cr
Supply Chain Management
-75.4%4.2%
₹32.85 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
100.0%
USA79.3%
Asia Pacific13.3%
Rest of the World7.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.00x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
0.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.